Skip to main content

This site is intended for healthcare professionals registered within the Republic of Ireland. If you are a member of the public, please click here.

Home

Register with E-mail  

  • Sign In
  • Home
  • Medicines
    • Cardiology
      • ENTRESTO® (sacubitril/valsartan)
      • LEQVIO® (Inclisiran)
    • Haematology
      • REVOLADE® (eltrombopag olamine)
    • Neuroscience
      • AIMOVIG® (erenumab)
    • Oncology
      • KISQALI® (ribociclib)
      • TAFINLAR® (dabrafenib) and MEKINIST® (trametinib)
    • Respiratory
      • ENERZAIR® BREEZHALER® (indacaterol/glycopyrronium/mometasone)
      • ULTIBRO® BREEZHALER® (indacaterol/glycopyrronium)
    • Rheumatology
      • COSENTYX® (secukinumab)
    • Managed Access Programs
    • All Novartis Products
    • Product Updates
      • Discontinuation Notices
  • Therapy Areas
    • Cardiology
      • ASCVD
      • Heart Failure
    • Neuroscience
      • Migraine
    • Respiratory
      • Asthma
      • COPD
  • Events and Webinars
    • Cardiology
      • Product events and webinars
      • Therapy area events and webinars
    • Neuroscience
      • Product events and webinars
      • Therapy area events and webinars
    • Respiratory
      • Product events and webinars
      • Therapy area events and webinars
  • News
  • Webshop
×

Ask Speakers

×

Medical Information Request

Welcome

This website is intended for healthcare professionals registered in the Republic of Ireland. By entering this website, you are confirming that you are a healthcare professional registered in the Republic of Ireland. This website may contain professional resources, therapy area materials and promotional information about Novartis Ireland Limited products.

I am a healthcare professional registered in the Republic of Ireland
I am a member of the public
  • Privacy Notice
  • Terms of use
  • Contact us
Sitemap
Cookie Settings
©2023 Novartis Ireland Limited.
All rights reserved
This site is intended only for Healthcare Professionals registered in the Republic of Ireland

 

Novartis Ireland Limited is a registered company in Ireland under number 11931.
Registered office: The Vista Building, Elm Park, Merrion Road, Ballsbridge, Dublin 4, D04A9N6, Ireland.

IE298087 | September 2023